Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pin-Nan Cheng

10PUBLICATIONS
32CO-AUTHORS
Metabolic medicineInstruments and techniquesMedical biochemistry - lipidsBehavioural epidemiologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Jan 18, 2025
Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).

Shih-Chieh Chien, Hung-Chih Chiu, Yen-Cheng Chiu

|Oct 29, 2024
Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus.

Jee-Fu Huang, Tien-Jyun Chang, Ming-Lun Yeh

|Apr 14, 2024
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry.

Rheun-Chuan Lee, Po-Chin Liang, Huei-Lung Liang

|Oct 17, 2023
Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B.

Pin-Nan Cheng, I-Cher Feng, Jyh-Jou Chen

|May 08, 2021
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).

Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen

|Feb 24, 2021
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.

Meng-Hsuan Hsieh, Ming-Jong Bair, Pei-Chien Tsai

Pageof 2

Frequent Collaborators

5 joint publications

Ming-Lung Yu

4 joint publications

Jia-Horng Kao

4 joint publications

Chun-Jen Liu

4 joint publications

Cheng-Yuan Peng

3 joint publications

Chih-Wen Lin

3 joint publications

Yi-Hsiang Huang

3 joint publications

Chao-Hung Hung

2 joint publications

Wei-Fan Hsu

2 joint publications

Chia-Chi Wang

2 joint publications

Kuo-Chih Tseng

Frequent Collaborators

5 joint publications

Ming-Lung Yu

4 joint publications

Jia-Horng Kao

4 joint publications

Chun-Jen Liu

4 joint publications

Cheng-Yuan Peng

Top Related Videos

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on : Mar 24, 2023

1.1K
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on : Jul 19, 2024

792
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

417
See more related videos

Top Related Videos

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel <em>In Vivo</em> Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on : Mar 24, 2023

1.1K
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on : Jul 19, 2024

792
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

417
See more related videos